Last reviewed · How we verify
NCT06203327
Atrophic Gastritis Predicts the Risk of Gastric Cancer
trial testing Esophagogastroscopy (OLGA 0-Ⅰ) in Atrophic Gastritis in 2,042 participants. Currently enrolling.
31 December 2034
Quick facts
| Lead sponsor | Shanghai Jiao Tong University School of Medicine |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,042 |
| Start date | 15 December 2023 |
| Primary completion | 31 December 2034 |
| Estimated completion | 31 December 2034 |
| Sites | 1 location across China |
Drugs / interventions tested
- Esophagogastroscopy (OLGA 0-Ⅰ)
- Esophagogastroscopy (OLGA II)
- Esophagogastroscopy (OLGA III-IV)
Conditions studied
- Atrophic Gastritis — all drugs for Atrophic Gastritis →
Sponsor
Shanghai Jiao Tong University School of Medicine
Who can join
Adults 18 to 70, any sex, with Atrophic Gastritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite declining incidence rates, gastric cancer (GC) ranks the fourth leading cause of cancer-related mortality and the fifth most common cancer worldwide, with the highest incidence reported in Eastern Asia. The 5-year overall survival rate of early GC exceeds 90%, which was well above advanced GC. Most intestinal-type GCs follow the Correa cascade-inflammation,atrophy, intestinal metaplasia (IM), dysplasia and subsequent carcinoma. The presence of gastric mucosal atrophy and intestinal metaplasia are important risk factors for GC. The purpose of this study was to investigate the incidence of GC attributed to atrophic gastritis in a region with high incidence of GC.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06203327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrophic Gastritis
Currently open trials in the same condition.
- NCT07388459 — Natural History, Evolution, and Clinical Features of Autoimmune Atrophic Gastritis · recruiting
- NCT05916014 — AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis · recruiting
- NCT04840056 — Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis · recruiting
- NCT04613570 — SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up · NA · recruiting
- NCT05053945 — Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study · recruiting
Other Shanghai Jiao Tong University School of Medicine trials
Trials by the same sponsor.
- NCT07570810 — Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM · NA · not yet recruiting
- NCT07528079 — Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors · NA · enrolling by invitation
- NCT07535710 — Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-ce · Phase 1, PHASE2 · not yet recruiting
- NCT07535762 — Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T · Phase 2 · not yet recruiting
- NCT07350057 — A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graf · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06203327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Jiao Tong University School of Medicine
- Last refreshed: 30 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06203327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing